Literature DB >> 16511386

Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings.

Ben J Marais1, Robert P Gie, Anneke C Hesseling, H Simon Schaaf, Donald A Enarson, Nulda Beyers.   

Abstract

BACKGROUND: The World Health Organization advises active tracing of children younger than 5 years old in household contact with a sputum smear-positive tuberculosis index case. This study compared radiographic disease manifestations in 2 groups of children treated for tuberculosis in an endemic setting: those who presented with suspicious symptoms; and those actively traced as household contacts of an adult index case.
METHODS: We conducted a prospective descriptive study from February 2003 through October 2004 at 5 primary health care clinics in Cape Town South Africa, including all children (younger than 5 years old) treated for tuberculosis (TB).
RESULTS: A total of 326 children (younger than 5 years old) received antituberculosis treatment; 190 (58.3%) presented with suspicious symptoms, and 136 (41.7%) were actively traced contacts. Children were categorized as; "not TB" 71 (22%), intrathoracic tuberculosis 230 (70%) and extrathoracic tuberculosis 25 (8%). Significantly more actively traced contacts were categorized as "not TB" (odds ratio, 7.4; 95% confidence interval, 3.8-14.3), or demonstrated elements of the primary complex only on the chest radiograph (odds ratio, 26.2; 95% confidence interval, 8.6-89.2), compared with children who presented with suspicious symptoms. Of all children diagnosed with intrathoracic tuberculosis, 20 of 230 (9%) reported no symptoms, all of whom demonstrated elements of the primary complex only.
CONCLUSIONS: The majority of actively traced contacts had minimal disease. Symptom-based screening would have identified all but 9% of children diagnosed with intrathoracic tuberculosis, all of whom demonstrated elements of the primary complex only. Further investigation is required to establish whether symptom-based screening can be justified to improve access to preventive chemotherapy in resource-limited endemic settings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511386     DOI: 10.1097/01.inf.0000202140.76368.74

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Contact investigation for active tuberculosis among child contacts in Uganda.

Authors:  Devan Jaganath; Sarah Zalwango; Brenda Okware; Mary Nsereko; Hussein Kisingo; LaShaunda Malone; Christina Lancioni; Alphonse Okwera; Moses Joloba; Harriet Mayanja-Kizza; W Henry Boom; Catherine Stein; Ezekiel Mupere
Journal:  Clin Infect Dis       Date:  2013-09-27       Impact factor: 9.079

2.  Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.

Authors:  C A Beneri; L Aaron; S Kim; P Jean-Philippe; S Madhi; A Violari; M F Cotton; C Mitchell; S Nachman
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

Review 3.  Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.

Authors:  Alexander W Kay; Tara Ness; Sabine E Verkuijl; Kerri Viney; Annemieke Brands; Tiziana Masini; Lucia González Fernández; Michael Eisenhut; Anne K Detjen; Anna M Mandalakas; Karen R Steingart; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2022-09-06

Review 4.  Recent advances in the diagnosis of childhood tuberculosis.

Authors:  Ben J Marais; Madhukar Pai
Journal:  Arch Dis Child       Date:  2007-05       Impact factor: 3.791

5.  Effect of Ascaris Lumbricoides specific IgE on tuberculin skin test responses in children in a high-burden setting: a cross-sectional community-based study.

Authors:  Nelda van Soelen; Anna M Mandalakas; H Lester Kirchner; Gerhard Walzl; Harleen M S Grewal; Marc Jacobsen; Anneke C Hesseling
Journal:  BMC Infect Dis       Date:  2012-09-11       Impact factor: 3.090

6.  Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.

Authors:  Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27

7.  Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016.

Authors:  Maya Mueller-Hermelink; Robin Kobbe; Benedikt Methling; Cornelius Rau; Ulf Schulze-Sturm; Isa Auer; Frank Ahrens; Folke Brinkmann
Journal:  Euro Surveill       Date:  2018-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.